Wall Street Rises Dow Hits Record High as Middle East Hopes Lift Sentiment Divis Laboratories Q4 Net Profit Rises 13 YoY to Rs 751 Crore Revenue Up 10 Board Recommends Rs 30 Dividend Micron Technology Stands Out as a Contrarian Opportunity Amid AI and Energy Frenzy Maxvolt Energy Targets South India Expansion With 73 Million Renewable Energy and Lithium Recycling Plan AIs Shadow Looms Over Japans NearRecord Graduate Employment Rate On Holding and LOEWE Unveil LightSpray Cloudmonster A Fusion of Performance and Luxury LMRI Q1 2026 Earnings Strong EPS Beat Masks Revenue Concerns and Stock Decline ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise TM Q1 2026 Earnings EPS Beat Driven by Cost Controls and Robust Global Sales MTRX Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism Ridgepost Capital Inc RPC Q1 2026 Earnings Slight EPS Beat Amid Mixed Signals Stock Slips SRRK Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress Allstate ALL Holds Steady Near Key Support After Modest Pullback Perpetua Resources PPTA Slips 15 as Stock Consolidates Between Key Support and Resistance Levels Kite Realty Group Trust Holds Steady Near 2748 as Support and Resistance Define Range QXO Inc QXO Edges Higher Approaches Key Resistance at 1856 Cognyte Software CGNT Slips 154 as Key Support Levels Come Into Focus Walmarts NonRetail Arm Emerges as Growth Engine but Premium Valuation Demands Proof CLDT Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Edges Higher RGC Resources RGCO Edges Higher as Stock Approaches Key Resistance Level DDS Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Reaction CDP Q1 2026 Earnings EPS Beats Estimates by 201 Shares Gain 148 TONX Q1 2026 Earnings Significant EPS Beat Drives 458 Stock Gain ZTO Q1 2026 Earnings Strong EPS Performance Amid Limited Disclosure Shattuck Labs Q1 2026 Earnings EPS Surprise Drives Positive Market Reaction AWK Q1 2026 Earnings EPS Falls Short of Estimates as Revenue Data Remains Unavailable Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn